Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Creative Realities Announces Reflect Settlement Agreement
-
Digi Power X Announces Nasdaq Ticker Symbol Change to DGXX
-
Auction result of Treasury Bills - RIKV 25 0521 - RIKV 25 0917
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Greencore Group plc
-
IREN Secures 2.75GW for Data Centers in West Texas with New 600MW Grid Connection Agreement
-
Navigator Gas Announces Completion of Acquisition of Three Handysize Liquefied Ethylene Gas Carriers
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Sprott Physical Copper Trust Announces Filing to List on NYSE Arca
-
SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results
-
Kraig Biocraft Laboratories Confirms Operations in Vietnam's Silk Production Hub, Lam Dong Province
-
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
-
Holding(s) in Company
-
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
-
Guardian Capital Announces March 2025 Cash Distributions for Guardian Capital ETFs
-
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
-
Ashland completes sale of Avoca business to Mane
-
Study Reveals Lack of Physician Oversight in Missouri Medical Spas, Raising Patient Safety Concerns from ASDSA
-
Americold Realty Trust, Inc. Declares First Quarter 2025 Dividend
-
K92 Mining Announces 2024 Q4 and Annual Financial Results – Record Quarterly Net Income, Operating Cash Flow, EBITDA, Metal Sold, Production and Recoveries; Annual Production, Cash Cost and AISC, Al
-
Orezone Gold Announces C$8.8 Million
-
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
-
Sprott Physical Gold Trust Net Asset Value Reaches $10 Billion
-
Greenheart Gold Provides an Update on Its Exploration Projects in Guyana
-
Salary.com to Explore Pay Trends for 2025 and Beyond During This Week’s ADP Meeting of the Minds
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the First Quarter of 2025
-
Bridger Aerospace Appoints Sam Davis Chief Executive Officer
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
RAAC Launches Testnet for $235m Gold-Backed RWA Platform
-
Tower Semiconductor Recognized by Northrop Grumman with Supplier Excellence Award
-
Precore Gold Corp. (formerly, Double Deuce Exploration Corp.): Change of Name and Trading Symbol
-
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
-
Bitfarms Advances U.S. Strategy with Completion of Stronghold Digital Mining Acquisition
-
Sonoco Issues 2024 Annual Report
-
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
-
Coda Octopus Group Reports Fiscal First Quarter 2025 Financial Results
-
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
-
Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System
-
Ashland completes sale of Avoca business to Mane
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Renasant and The First Announce Receipt of Regulatory Approvals for Merger
-
Diversified Achieves Strong Final Year-End 2024 Results, Delivers on Capital Allocation Promises, and Introduces 2025 Combined Company Outlook
-
Castellum, Inc.’s Subsidiary GTMR Achieves CMMI Level 3 Appraisal
-
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
-
Descartes Study: 39% of High-growth Companies Leverage Trade Compliance as Competitive Advantage
-
Transactions in connection with share buyback programme
-
Transactions under Novonesis’ share buyback program
-
Orezone Provides Notice of 2024 Year-End Results and 2025 Guidance
-
Namib Minerals and Hennessy Capital Investment Corp. VI Announce Effectiveness of Registration Statement and Record and Meeting Dates for Special Meeting of Stockholders to Approve Proposed Business C
